Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficient correction of hemoglobinopathy-causing mutations by homologous recombination in integration-free patient iPSCs

22 Nov 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics and Rare Diseases
Share to Hemoglobinopathies and Related Disorders
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22105484
DOI: 10.1038/cr.2011.186

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficient correction of hemoglobinopathy-causing mutations by homologous recombination in integration-free patient iPSCsPMID 22105484Read ↗

Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells.Semantic proximity Read ↗

Gene therapy for hemoglobinopathies: progress and challenges.Semantic proximity Read ↗

Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice.Semantic proximity Read ↗

Homologous Recombination in Human Embryonic Stem Cells: A Tool for Advancing Cell Therapy and Understanding and Treating Human DiseaseSemantic proximity Read ↗

Selection-free, high frequency genome editing by homologous recombination of human pluripotent stem cells using Cas9 RNP and AAV6Semantic proximity Read ↗

Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cellsSemantic proximity Read ↗

Prospects and challenges of in vivo hematopoietic stem cell genome editing for hemoglobinopathiesSemantic proximity Read ↗

Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.Semantic proximity Read ↗

A more efficient method to generate integration-free human iPS cellsSemantic proximity Read ↗

Efficient repair of human homozygous genetic mutation by CRISPR/Cas9 mediated interlocus gene conversionSemantic proximity Read ↗

Gene Therapy for HemoglobinopathiesSemantic proximity Read ↗

Gene Therapy for HemoglobinopathiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.